Postoperative Radiation Therapy (PORT) Is Associated With Better Survival in Non-Small Cell Lung Cancer With Involved N2 Lymph Nodes

被引：0
|
作者：
Mikell, J. L. [1 ,2 ]
Gillespie, T. W. [2 ,3 ]
Hall, W. A. [1 ,2 ]
Nickleach, D. C. [2 ,4 ]
Liu, Y. [2 ,4 ]
Lipscomb, J. [2 ,3 ]
Ramalingam, S. S. [2 ,5 ]
Rajpara, R. S. [1 ,2 ]
Force, S. D. [2 ,6 ]
Fernandez, F. G. [2 ,6 ]
Owonikoko, T. K. [2 ,5 ]
Pillai, R. N. [2 ,5 ]
Khuri, F. R. [2 ,5 ]
Jegadeesh, N. K. [1 ,2 ]
Curran, W. J. [1 ,2 ]
Higgins, K. A. [1 ,2 ]
机构：
[1] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Winship Canc Inst, Atlanta, GA USA
[3] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Hematol & Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.08.167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] SURVIVAL OF PATIENTS WITH UNSUSPECTED N2 (STAGE IIIA) NON-SMALL CELL LUNG CANCER
    Park, Chang Kwon
    Lee, Deok Heon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S883 - S883
  • [32] Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer
    Huang, Xinyi
    Hu, Pingping
    Yan, Fei
    Zhang, Jiandong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [33] Adjuvant Radiation Therapy Improves Survival in Pathological Stage IIIA N2 Non-Small Cell Lung Cancer Patients Staged with PET
    Tin, Mo Mo
    Kennedy, Catherine
    Wong, Daniel
    Tse, Regina
    Boyer, Michael
    Mccaughan, Brian
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S575 - S576
  • [34] Analysis of Real World Data To Evaluate Survival Benefit of Radiation Therapy in Stage III / N2 Non-Small Cell Lung Cancer
    Spina, C. S.
    Russell, A.
    Eichler, G.
    Cheng, S. K.
    Stepanski, E.
    Hyde, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E532 - E532
  • [35] Improved survival in N2 non-small cell lung cancer: better staging or better treatment; a SEER database retrospective cohort analysis
    Kamel, Mohamed K.
    Lee, Benjamin
    Harrison, Sebron
    Port, Jeffrey
    Altorki, Nasser K.
    VIDEO-ASSISTED THORACIC SURGERY, 2022,
  • [36] The role of surgery in N2 non-small cell lung cancer
    DeCamp, MM
    Ashiku, S
    Thurer, R
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5033S - 5037S
  • [37] Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer
    Rieber, J.
    Deeg, A.
    Muley, T.
    Kappes, J.
    Foerster, R.
    Heussel, C. P.
    Welzel, T.
    Thomas, M.
    Steins, M.
    Hoffmann, H.
    Debus, J.
    Rieken, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S132 - S133
  • [38] Prognostic Value of Lymph Node Ratio (LNR) in Patients with Postoperative N2 Feature in Non-Small Cell Lung Cancer (NSCLC)
    Lochowski, Mariusz Piotr
    Chalubinska-Fendler, Justyna
    Szlachcinska, Aleksandra
    Lochowska, Barbara
    Brzezinski, Daniel
    Kaczmarski, Jacek
    Kozak, Jozef
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [39] Current Surgical Therapy for Stage IIIA (N2) Non-Small Cell Lung Cancer
    Yanagawa, Jane
    Rusch, Valerie W.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2011, 23 (04) : 291 - 296
  • [40] Preoperative Therapy is Not Required for Clinically Occult N2 Non-Small Cell Lung Cancer
    Kamel, Mohamed
    Ghaly, Galal
    Nasar, Abu
    Port, Jeffrey
    Stiles, Brendon
    Altorki, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1447 - S1447
12345